We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App




Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021 (Photo courtesy of Jiangsu Bioperfectus Technologies Co., Ltd.)
Image: Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021 (Photo courtesy of Jiangsu Bioperfectus Technologies Co., Ltd.)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) demonstrated its range of nucleic acid extraction solutions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

The event brought together 20,000 of the sharpest minds in clinical laboratory medicine for four science packed days. At the conference, attendees heard from the foremost experts on topics from personalized medicine and infectious diseases to point-of-care and laboratory-developed tests. At the Clinical Lab Expo, attendees evaluated hundreds of new technologies just coming to market that can enhance their lab.

At AACC 2021, Bioperfectus showcased its new SMPE-960 nucleic acid extraction system which is an in vitro diagnostic medical device that integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples with a modular structure - the equipment can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Each module consists of 1-32 samples so that samples can be tested upon delivery.

Bioperfectus also displayed its Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) which uses magnetic beads and a buffer system with unique separation function. The kit is used in conjunction with the SMPE-960 nucleic acid extraction system to separate and purify high-quality viral nucleic acids from samples. The specially coated magnetic beads have a strong affinity for the nucleic acid in the sample under certain conditions. When the conditions change, the magnetic beads release the adsorbed nucleic acid, so that the nucleic acid in the purified sample can be quickly extracted. This kit is used for the extraction and purification of viral nucleic acids (DNA and RNA) from samples such as serum, plasma, virus culture fluid, cerebrospinal fluid, urine, swab wash, fecal supernatant, etc. The purified nucleic acid can be used in downstream molecular biology experiment.

Also on display at the event was the COVID-19 Coronavirus (ORF1ab/N/E) Real Time PCR Kit from Bioperfectus that is an In Vitro Diagnostic (IVD) reagent relying on fluorescent PCR technology and aiming at qualitatively detection and differentiation of human RNA from SARS-CoV-2 from upper and lower respiratory tract samples. Primer and probe are selected from Open Reading Frame gene region (ORF1a/b), envelope protein (E) and nucleocapsid region (N) for SARS-CoV-2. The kit is a multiplex assay, run in a single well/vessel, designed for detection and differentiation of RNA from SARS-CoV-2. In addition, the kit also contains human house-keeping gene (RNase P) for clinical sample detection. The product is intended for use on populations suspected to have SARS-CoV-2 infection, as an aid in the diagnosis of SARS-CoV-2 infection by trained laboratory personnel on RT-PCR.

In addition, Bioperfectus highlighted its Viral Nucleic Acid Extraction Kit (Magnetic Bead Method) which uses magnetic beads and a buffer system with unique separation function. The kit is used in conjunction with the SMPE-960 nucleic acid extraction system to separate and purify high-quality viral nucleic acids from samples. The specially coated magnetic beads have a strong affinity for the nucleic acid in the sample under certain conditions. When the conditions change, the magnetic beads release the adsorbed nucleic acid, so that the nucleic acid in the purified sample can be quickly extracted. This kit is used for the extraction and purification of viral nucleic acids (DNA and RNA) from samples such as serum, plasma, virus culture fluid, cerebrospinal fluid, urine, swab wash, fecal supernatant, etc. The purified nucleic acid can be used in a downstream molecular biology experiment.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.